Literature DB >> 24651743

Small, short-duration, dobutamine-induced perfusion defects are not associated with adverse prognosis in intermediate-risk individuals receiving cardiovascular magnetic resonance stress imaging.

Jennifer H Jordan1, Jason C Haag, Timothy M Morgan, Sujethra Vasu, Brandon Stacey, Craig Hamilton, Killian Robinson, Dalane Kitzman, Vinay Thohan, William Gregory Hundley.   

Abstract

OBJECTIVE: The objective of this study was to assess the frequency and prognostic utility of small, short-duration left ventricular myocardial perfusion defects during dobutamine cardiovascular magnetic resonance (DCMR) stress imaging.
METHODS: We performed first-pass contrast-enhanced DCMR at peak stress in 331 consecutively recruited individuals (aged 68 ± 8 years, 50% men) at intermediate risk for a future cardiac event. Size, location, and persistence of low-signal intensity perfusion defects were recorded. Cardiac events were assessed by personnel blinded to imaging results for a median of 24 months after the DCMR.
RESULTS: Among the 55 individuals (16.6%) who exhibited small (<25% myocardial thickness) and short-duration (<5 frames in persistence) perfusion defects, diabetes was more prevalent (P = 0.019) and no cardiac events were observed. Large, persistent perfusion defects were associated with coronary artery disease, prior myocardial infarction, and decreased left ventricular function (P < 0.001 for all) and increased 2-year risk for a cardiac event (hazard ratio, 10.3; P < 0.001; confidence interval, 3.3-33.0).
CONCLUSIONS: In individuals with diabetes, hypertension, or coronary artery disease at intermediate risk for a future cardiac event, small, short-duration DCMR perfusion defects are not associated with increased 2-year risk for a subsequent cardiac event.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24651743      PMCID: PMC4103171          DOI: 10.1097/RCT.0000000000000046

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  25 in total

1.  Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging.

Authors:  Igor Klem; John F Heitner; Dipan J Shah; Michael H Sketch; Victor Behar; Jonathan Weinsaft; Peter Cawley; Michele Parker; Michael Elliott; Robert M Judd; Raymond J Kim
Journal:  J Am Coll Cardiol       Date:  2006-03-27       Impact factor: 24.094

2.  Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease.

Authors:  Raymond Y Kwong; Anna K Chan; Kenneth A Brown; Carmen W Chan; H Glenn Reynolds; Sui Tsang; Roger B Davis
Journal:  Circulation       Date:  2006-06-05       Impact factor: 29.690

3.  On the dark rim artifact in dynamic contrast-enhanced MRI myocardial perfusion studies.

Authors:  E V R Di Bella; D L Parker; A J Sinusas
Journal:  Magn Reson Med       Date:  2005-11       Impact factor: 4.668

Review 4.  Imaging sequences for first pass perfusion --a review.

Authors:  Peter Kellman; Andrew E Arai
Journal:  J Cardiovasc Magn Reson       Date:  2007       Impact factor: 5.364

5.  A note on quantifying follow-up in studies of failure time.

Authors:  M Schemper; T L Smith
Journal:  Control Clin Trials       Date:  1996-08

6.  Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography.

Authors:  W G Hundley; C A Hamilton; M S Thomas; D M Herrington; T B Salido; D W Kitzman; W C Little; K M Link
Journal:  Circulation       Date:  1999-10-19       Impact factor: 29.690

7.  Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging.

Authors:  Cosima Jahnke; Eike Nagel; Rolf Gebker; Thomas Kokocinski; Sebastian Kelle; Robert Manka; Eckart Fleck; Ingo Paetsch
Journal:  Circulation       Date:  2007-03-12       Impact factor: 29.690

8.  Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography.

Authors:  E Nagel; H B Lehmkuhl; W Bocksch; C Klein; U Vogel; E Frantz; A Ellmer; S Dreysse; E Fleck
Journal:  Circulation       Date:  1999-02-16       Impact factor: 29.690

9.  Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischaemia: experience in 1000 consecutive cases.

Authors:  Andreas Wahl; Ingo Paetsch; Albrecht Gollesch; Stefan Roethemeyer; Daniela Foell; Rolf Gebker; Holger Langreck; Christoph Klein; Eckart Fleck; Eike Nagel
Journal:  Eur Heart J       Date:  2004-07       Impact factor: 29.983

10.  Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion.

Authors:  I Paetsch; C Jahnke; A Wahl; R Gebker; M Neuss; E Fleck; E Nagel
Journal:  Circulation       Date:  2004-08-02       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.